Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000501828 | SCV000593470 | likely benign | not specified | 2018-02-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004955552 | SCV005497469 | uncertain significance | Inborn genetic diseases | 2024-11-26 | criteria provided, single submitter | clinical testing | The c.5696G>C (p.R1899P) alteration is located in exon 12 (coding exon 12) of the ASXL3 gene. This alteration results from a G to C substitution at nucleotide position 5696, causing the arginine (R) at amino acid position 1899 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |